UroGen Pharma Ltd (URGN) — Long-term Investment Intensity
UroGen Pharma Ltd (URGN) has a Long-term Investment Intensity of 0.2% as of September 2025. Long-term investments of $380.00K represent 0.2% of total assets of $185.05 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check URGN cash and liquid asset ratio to evaluate the company's liquid asset resilience ratio.
LT Investment Intensity
Long-term Investments
Total Assets
Country
UroGen Pharma Ltd Long-term Investment Intensity (2019–2024)
This chart shows how UroGen Pharma Ltd's Long-term Investment Intensity has evolved across 5 annual periods from 2019 to 2024. As of September 2025, the intensity stands at 0.2%, reflecting long-term investments of $380.00K against total assets of $185.05 Million USD. For the complete balance sheet picture, see UroGen Pharma Ltd (URGN) total assets.
Annual Long-term Investment Intensity for UroGen Pharma Ltd (2019–2024)
The table below presents the year-by-year Long-term Investment Intensity for UroGen Pharma Ltd from 2019 to 2024, covering 5 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. Read UroGen Pharma Ltd (URGN) total liabilities for a breakdown of total debt and financial obligations.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2024 | 1.8% | $5.02 Million | $285.71 Million | ▼ -0.8 pp |
| 2023 | 2.5% | $4.50 Million | $178.31 Million | ▲ +2.0 pp |
| 2021 | 0.6% | $675.00K | $119.75 Million | ▼ -1.0 pp |
| 2020 | 1.6% | $1.89 Million | $122.00 Million | ▼ -22.4 pp |
| 2019 | 24.0% | $48.55 Million | $202.39 Million | — |